Drug Therapy, Combination
"Drug Therapy, Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Therapy with two or more separate preparations given for a combined effect.
Concept/Terms
Drug Therapy, Combination- Drug Therapy, Combination
- Combination Chemotherapy
- Drug Polytherapy
- Drug Polytherapies
- Polytherapies, Drug
- Polytherapy, Drug
- Therapy, Combination Drug
- Chemotherapy, Combination
- Chemotherapies, Combination
- Combination Chemotherapies
- Combination Drug Therapy
- Combination Drug Therapies
- Drug Therapies, Combination
- Therapies, Combination Drug
Below are MeSH descriptors whose meaning is more general than "Drug Therapy, Combination".
Below are MeSH descriptors whose meaning is more specific than "Drug Therapy, Combination".
This graph shows the total number of publications written about "Drug Therapy, Combination" by people in Harvard Catalyst Profiles by year, and whether "Drug Therapy, Combination" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1993 | 3 | 32 | 35 |
1994 | 5 | 44 | 49 |
1995 | 4 | 47 | 51 |
1996 | 4 | 63 | 67 |
1997 | 1 | 56 | 57 |
1998 | 1 | 90 | 91 |
1999 | 4 | 90 | 94 |
2000 | 2 | 104 | 106 |
2001 | 1 | 91 | 92 |
2002 | 0 | 109 | 109 |
2003 | 2 | 121 | 123 |
2004 | 3 | 145 | 148 |
2005 | 4 | 128 | 132 |
2006 | 3 | 142 | 145 |
2007 | 1 | 149 | 150 |
2008 | 0 | 173 | 173 |
2009 | 1 | 177 | 178 |
2010 | 2 | 162 | 164 |
2011 | 2 | 146 | 148 |
2012 | 7 | 149 | 156 |
2013 | 4 | 163 | 167 |
2014 | 1 | 130 | 131 |
2015 | 3 | 177 | 180 |
2016 | 4 | 198 | 202 |
2017 | 4 | 195 | 199 |
2018 | 2 | 157 | 159 |
2019 | 2 | 176 | 178 |
2020 | 3 | 135 | 138 |
2021 | 3 | 106 | 109 |
2022 | 0 | 57 | 57 |
2023 | 0 | 13 | 13 |
Below are the most recent publications written about "Drug Therapy, Combination" by people in Profiles.
-
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications. Int J Tuberc Lung Dis. 2023 Jun 01; 27(6):451-457.
-
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials. Eur Heart J. 2023 03 14; 44(11):954-968.
-
How Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis to High-Income Settings? Clin Infect Dis. 2023 03 04; 76(5):944-949.
-
Reduced Asthma Exacerbations by the Addition of Inhaled Corticosteroids to Rescue Therapy in Black and Latinx Adults. J Allergy Clin Immunol Pract. 2023 Mar; 11(3):968-969.
-
Retrospective analysis of the risk of hyperkalaemia in women older than 65 years of age prescribed spironolactone for female-pattern hair loss. Br J Dermatol. 2023 02 22; 188(3):429-447.
-
P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions. J Am Coll Cardiol. 2023 Feb 14; 81(6):537-552.
-
Optimal Antiplatelet Therapy Revisited: When Is a Single Better Than a Double? J Am Coll Cardiol. 2023 Feb 14; 81(6):553-556.
-
Benefit of Combination Ezetimibe/Simvastatin Among High-Risk Populations: Lessons from the IMPROVE-IT Trial. Curr Atheroscler Rep. 2023 Mar; 25(3):85-93.
-
High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis. PLoS One. 2023; 18(2):e0281155.
-
Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer. Nat Commun. 2023 02 08; 14(1):695.